Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
收藏DataCite Commons2022-05-27 更新2024-07-29 收录
下载链接:
https://scielo.figshare.com/articles/dataset/Comparison_of_two_commercial_tests_Immy_vs_Dynamiker_for_cryptococcal_capsular_antigen/19905302/1
下载链接
链接失效反馈官方服务:
资源简介:
Abstract INTRODUCTION Lateral flow assay is an advanced method useful in the early diagnosis of cryptococcal meningitis. We aimed to compare two commercial tests for cryptococcal capsular antigen in the sera of asymptomatic patients with human immunodeficiency virus in Barranquilla, Colombia. METHODS Thawed (n=162) previously collected serums (2016-2019) were processed using IMMY and Dynamiker cryptococcal antigen lateral flow assay. RESULTS Compared to IMMY’s results, Dynamiker’s sensitivity, specificity, positive predictive value, negative predictive value, and kappa index were 100%, 89.9%, 48.3%, 100.0%, and 0.61, respectively. CONCLUSIONS The Dynamiker test had excellent sensitivity, acceptable specificity, and a low detection threshold for cryptococcal antigen in the tested samples.
提供机构:
SciELO journals
创建时间:
2022-05-27



